Bone marrow osteoblast vulnerability to chemotherapy

European Journal of Haematology

Volumn 90, Issue 6, 2013, Pages 469-478

  Gencheva, Marieta ^a   Hare, Ian ^a   Kurian, Susan ^a   Fortney, Jim ^a   Piktel, Debbie ^a   Wysolmerski, Robert ^a   Gibson, Laura F ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Bone marrow microenvironment; Chemotherapy; Extracellular matrix; Hematopoietic stem cell; Osteoblast

Indexed keywords

COLLAGEN; ETOPOSIDE; MELPHALAN; OSTEOCALCIN; OSTEOPONTIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL HOMING; CELL MATURATION; CHEMOTHERAPY; CONTROLLED STUDY; CYTOARCHITECTURE; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; EXTRACELLULAR MATRIX; HEMATOPOIETIC CELL; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STABILITY;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE; CHEMOKINE CXCL12; COLLAGEN TYPE I; ETOPOSIDE; EXTRACELLULAR MATRIX; HEMATOPOIETIC STEM CELLS; HUMANS; MELPHALAN; MICE; OSTEOBLASTS; OSTEOCALCIN; OSTEOPONTIN; STEM CELL NICHE;

EID: 84878143633     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12109     Document Type: Article

References (37)

1. Morrison SJ, Spradling AC. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 2008;132:598-611.
2. Mercier FE, Ragu C, Scadden DT. The bone marrow at the crossroads of blood and immunity. Nat Rev Immunol 2011;12:49-60.
3. Nagasawa T, Omatsu Y, Sugiyama T. Control of hematopoietic stem cells by the bone marrow stromal niche: the role of reticular cells. Trends Immunol 2011;32:315-20.
4. Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005;121:1109-21.
5. Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012;481:457-62.
6. Sugiyama T, Kohara H, Noda M, Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006;25:977-88.
7. Omatsu Y, Sugiyama T, Kohara H, Kondoh G, Fujii N, Kohno K, Nagasawa T. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 2010;33:387-99.
8. Méndez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A, Enikolopov GN, Frenette PS. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010;466:829-34.
9. Sacchetti B, Funari A, Michienzi S, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007;131:324-36.
10. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003;425:841-6.
11. Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003;425:836-41.
12. Visnjic D, Kalajzic Z, Rowe DW, Katavic V, Lorenzo J, Aguila HL. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 2004;103:3258-64.
13. Zhu J, Garrett R, Jung Y, et al. Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. Blood 2007;109:3706-12.
14. Nakashima K, De Crombrugghe B. Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet 2003;19:458-66.
15. Kalajzic I, Kalajzic Z, Kaliterna M, Gronowicz G, Clark SH, Lichtler AC, Rowe D. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res 2002;17:15-25.
16. Pommier Y, Leo E, Zhang H, Marchand C. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 2010;17:421-33.
17. Hall AG, Tilby MJ. Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies. Blood Rev 1992;6:163-73.
18. Guest I, Uetrecht J. Drugs toxic to the bone marrow that target the stromal cells. Immunopharmacology 2000;46:103-12.
19. Davies JH, Evans BAJ, Jenney MEM, Gregory JW. In vitro effects of chemotherapeutic agents on human osteoblast-like cells. Calcif Tissue Int 2002;70:408-15.
20. Tauchmanovà L, Serio B, Del Puente A, Risitano AM, Esposito A, Del Rosa G, Lombardi G, Colao A, Rotoli B, Selleri C. Long-lasting bone damage detected by dual-energy x-ray absorptiometry, phalangeal osteosonogrammetry, and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation. J Clin Endocrinol Metab 2002;87:5058-65.
21. Rellick SL, O'Leary H, Piktel D, et al. Bone marrow osteoblast damage by chemotherapeutic agents. PLoS ONE 2012;7:e30758.
22. Corazza F, Hermans C, Ferster A, Fondu P, Demulder A, Sariban E. Bone marrow stroma damage induced by chemotherapy for acute lymphoblastic leukemia in children. Pediatr Res 2004;55:152-8.
23. Davies JH, Evans BAJ, Jenney MEM, Gregory JW. Effects of chemotherapeutic agents on the function of primary human osteoblast-like cells derived from children. J Clin Endocrinol Metab 2003;88:6088-97.
24. Reichert JC, Burke LJ, Clements JA, Hutmacher DW. Preparation of mineralised matrices secreted from human primary osteoblasts for analysis of the interaction of cancer cells and the bone microenvironment. Protoc. Exch. 2008 [Internet] [cited 2012 June 12]. 10.1038/nprot.2008.237.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-8.
26. Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup RJ. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res 1992;7:683-92.
27. Thompson DL, Lum KD, Nygaard SC, Kuestner RE, Kelly KA, Gimble JM, Moore EE. The derivation and characterization of stromal cell lines from the bone marrow of p53-/- mice: new insights into osteoblast and adipocyte differentiation. J Bone Miner Res 1998;13:195-204.
28. Nakamura Y, Arai F, Iwasaki H, Hosokawa K, Kobayashi I, Gomei Y, Matsumoto Y, Yoshihara H, Suda T. Isolation and characterization of endosteal niche cell populations that regulate hematopoietic stem cells. Blood 2010;116:1422-32.
29. Spangrude GJ, Brooks DM. Mouse strain variability in the expression of the hematopoietic stem cell antigen Ly-6A/E by bone marrow cells. Blood 1993;82:3327-32.
30. Kondo M, Wagers AJ, Manz MG, Prohaska SS, Scherer DC, Beilhack GF, Shizuru JA, Weissman IL. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol 2003;21:759-806.
31. Kalajzic I, Staal A, Yang W-P, et al. Expression profile of osteoblast lineage at defined stages of differentiation. J Biol Chem 2005;280:24618-26.
32. Moskovits N, Kalinkovich A, Bar J, Lapidot T, Oren M. p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts. Cancer Res 2006;66:10671-6.
33. Nilsson SK, Johnston HM, Whitty GA, Williams B, Webb RJ, Denhardt DT, Bertoncello I, Bendall LJ, Simmons PJ, Haylock DN. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 2005;106:1232-9.
34. Bredemeyer AL, Helmink BA, Innes CL, et al. DNA double-strand breaks activate a multi-functional genetic program in developing lymphocytes. Nature 2008;456:819-23.
35. Zheng H, Ying H, Yan H, et al. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 2008;455:1129-33.
36. Inomata K, Aoto T, Binh NT, et al. Genotoxic stress abrogates renewal of melanocyte stem cells by triggering their differentiation. Cell 2009;137:1088-99.
37. Puri PL, Bhakta K, Wood LD, Costanzo A, Zhu J, Wang JYJ. A myogenic differentiation checkpoint activated by genotoxic stress. Nat Genet 2002;32:585-93.